|

mFOLFIRINOX or Gemcitabine nab-paclitaxel Clinical Trials

1 actively recruiting trial

Also known as: mFFX or Gem/Nab-p

Pipeline

Phase 2: 1

Top Sponsors

  • Erasme University Hospital1

Indications

  • Borderline Resectable Pancreatic Adenocarcinoma1
  • Pancreatic Neoplasm1
  • Pancreatic Adenocarcinoma1
  • Cancer1

Other1 trial

Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.